Quantification of glycated hemoglobin and glucose in vivo using Raman spectroscopy and artificial neural networks.
Ontology highlight
ABSTRACT: Undiagnosed type 2 diabetes (T2D) remains a major public health concern. The global estimation of undiagnosed diabetes is about 46%, being this situation more critical in developing countries. Therefore, we proposed a non-invasive method to quantify glycated hemoglobin (HbA1c) and glucose in vivo. We developed a technique based on Raman spectroscopy, RReliefF as a feature selection method, and regression based on feed-forward artificial neural networks (FFNN). The spectra were obtained from the forearm, wrist, and index finger of 46 individuals. The use of FFNN allowed us to achieve an error in the predictive model of 0.69% for HbA1c and 30.12 mg/dL for glucose. Patients were classified according to HbA1c values into three categories: healthy, prediabetes, and T2D. The proposed method obta
SUBMITTER: Gonzalez-Viveros N
PROVIDER: S-EPMC9708775 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA